Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Young-Onset Cancers-Early Steps in the Right Direction.
Barreto SG, Ben-Aharon I. Barreto SG, et al. Among authors: ben aharon i. Cancers (Basel). 2023 May 4;15(9):2599. doi: 10.3390/cancers15092599. Cancers (Basel). 2023. PMID: 37174065 Free PMC article.
Controversies in upper GI oncology: early-onset gastric cancer.
Petrillo A, Alsina M, Ben-Aharon I. Petrillo A, et al. Among authors: ben aharon i. ESMO Open. 2024 Apr 24;9(5):102925. doi: 10.1016/j.esmoop.2024.102925. Online ahead of print. ESMO Open. 2024. PMID: 38663169 Free PMC article. No abstract available.
Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC.
Almog G, Pfeffer RM, Zalmanov S, Grinberg V, Lipsky Y, Chernomordikov E, Levin D, Apter S, Arsenault O, Epstein D, Tamimi Q, Hod K, Limon D, Golan T, Ben-Aharon I, Lawrence YR, Ben-David MA. Almog G, et al. Among authors: ben aharon i. Front Oncol. 2023 Nov 24;13:1289919. doi: 10.3389/fonc.2023.1289919. eCollection 2023. Front Oncol. 2023. PMID: 38074644 Free PMC article.
Gender Gap in Leadership of Clinical Trials.
Waldhorn I, Bomze D, Ben-Aharon I, Schlosser S, Markel G, Ludmir EB, Meirson T. Waldhorn I, et al. Among authors: ben aharon i. JAMA Intern Med. 2023 Dec 1;183(12):1406-1408. doi: 10.1001/jamainternmed.2023.5104. JAMA Intern Med. 2023. PMID: 37902723
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Clinical Trial.
101 results